Crohn's Disease (cd) Clinical Trials
2 recruiting trials for Crohn's Disease (cd). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Crohn's Disease (cd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Glasgow (1), University of North Carolina, Chapel Hill (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is enteral nutrition (dietary_supplement, 1 trial).
Track Crohn's Disease (cd) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
Crohn's disease (CD) is a chronic, incurable condition associated with gut inflammation. Two important treatments currently used to manage CD are special drug injections...
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Crohn's Disease (cd), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Crohn's Disease (cd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Crohn's Disease (cd), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.